Melanoma-Derived Exosomes Induce PD-1 Overexpression and Tumor Progression via Mesenchymal Stem Cell Oncogenic Reprogramming

Recently, it has been described that programmed cell death protein 1 (PD-1) overexpressing melanoma cells are highly aggressive. However, until now it has not been defined which factors lead to the generation of PD-1 overexpressing subpopulations. Here, we present that melanoma-derived exosomes, con...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2019-10, Vol.10, p.2459
Hauptverfasser: Gyukity-Sebestyén, Edina, Harmati, Mária, Dobra, Gabriella, Németh, István B, Mihály, Johanna, Zvara, Ágnes, Hunyadi-Gulyás, Éva, Katona, Róbert, Nagy, István, Horváth, Péter, Bálind, Árpád, Szkalisity, Ábel, Kovács, Mária, Pankotai, Tibor, Borsos, Barbara, Erdélyi, Miklós, Szegletes, Zsolt, Veréb, Zoltán J, Buzás, Edit I, Kemény, Lajos, Bíró, Tamás, Buzás, Krisztina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Recently, it has been described that programmed cell death protein 1 (PD-1) overexpressing melanoma cells are highly aggressive. However, until now it has not been defined which factors lead to the generation of PD-1 overexpressing subpopulations. Here, we present that melanoma-derived exosomes, conveying oncogenic molecular reprogramming, induce the formation of a melanoma-like, PD-1 overexpressing cell population (mMSC ) from naïve mesenchymal stem cells (MSCs). Exosomes and mMSC cells induce tumor progression and expression of oncogenic factors . Finally, we revealed a characteristic, tumorigenic signaling network combining the upregulated molecules (e.g., PD-1, MET, RAF1, BCL2, MTOR) and their upstream exosomal regulating proteins and miRNAs. Our study highlights the complexity of exosomal communication during tumor progression and contributes to the detailed understanding of metastatic processes.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2019.02459